Sickle Cell Disease Care Avoidance Follows Barriers Across Social, Economic, and Institutional Levels
A scoping review in sickle cell disease found that healthcare avoidance is not driven by a single failure point. It emerges from repeated friction across social, interpersonal, economic, and institutional domains, each shaping whether people living with sickle cell disease in the United States seek care when pain or complications escalate.
The review screened 708 articles and included 70 that met criteria for healthcare utilization among people living with sickle cell disease in the U.S. The pattern was consistent: barriers were more numerous and more deeply embedded than the supports designed to overcome them. Social factors appeared most often, followed by interpersonal, economic, and institutional barriers. In a condition marked by severe pain, organ injury, and unpredictable acute episodes, those obstacles can steer patients away from the very systems meant to stabilize them.
Utilization Patterns Centered on the Hospital and Emergency Department
In the included literature, inpatient or hospital admissions were the most common form of healthcare utilization, with emergency department visits close behind. That pattern fits the clinical course of sickle cell disease, where vaso-occlusive pain crises, acute anemia, infection, and end-organ complications can force urgent care decisions rather than planned outpatient management. When access is inconsistent or trust is low, the system becomes reactive instead of preventive.
One sentence captures the clinical strain plainly: people often enter care only when symptoms have already become difficult to manage at home.
The review’s findings also suggest that utilization is shaped less by willingness alone than by the practical realities of getting care accepted, affordable, and coordinated. Emergency departments remain a default entry point when routine follow-up is fragmented, but repeated negative encounters can reinforce avoidance in future episodes. For a chronic genetic disorder with a high acute-care burden, that cycle carries obvious consequences for pain control, patient confidence, and downstream complications.
Social and Interpersonal Friction Remain Central Barriers
Social barriers were the most frequently identified obstacle in the literature, appearing in 25 studies. Interpersonal barriers followed closely in 23. Those categories capture the lived experience of sickle cell disease care: family demands, transportation problems, stigma, dismissal of pain, and strained communication with clinicians can all shape whether care is sought or delayed.
The interpersonal side matters because sickle cell disease care often depends on rapid recognition of pain severity and consistent response from clinicians. When patients anticipate disbelief or inadequate treatment, they may postpone seeking help even during escalating symptoms. That dynamic is especially damaging in a disease where delayed treatment can turn a manageable pain episode into a prolonged hospitalization.
Economic barriers appeared in 15 studies and institutional barriers in 11. Cost, insurance complexity, clinic access, and fragmented systems all contribute to avoidable gaps in care. In practice, those barriers do not operate separately. A patient may face transportation difficulty, limited appointment availability, financial pressure, and a prior history of poor communication all at once, creating a cumulative burden that can overwhelm even strong motivation to engage with healthcare.
Technology, Education, Autonomy, and Trust Emerge as Facilitators
The most common facilitators were technology, education, autonomy, and positive patient-provider relationships. Technology appeared in nine studies, education in seven, and autonomy as well as positive patient-provider relationships in six each. Those findings point to a practical truth: care is more likely to be used when systems reduce friction and give patients clearer control over their treatment path.
Technology may help by improving communication, coordination, and access to guidance between acute episodes. Education can strengthen self-management and prepare patients to recognize worsening symptoms earlier. Autonomy matters because patients with chronic pain and repeated encounters often need treatment plans that respect their experience and preferences rather than override them. A strong patient-provider relationship may be the most immediate facilitator of all, because trust can lower the threshold for seeking help and improve adherence to agreed plans.
One especially concrete signal emerged from the interventions identified as reducing healthcare avoidance. Individualized pain plans appeared in four studies, and quality improvement strategies appeared in three. Both approaches point toward a system that responds to the patient with some consistency instead of forcing each crisis to be negotiated from scratch.
Individualized Pain Plans Offer a Direct Bedside Response
Individualized pain plans are clinically attractive because they translate prior knowledge of a patient’s disease course into action during the next acute episode. For sickle cell disease, where pain crises are recurrent and often intensely personal in presentation, a prearranged plan can reduce uncertainty on both sides of the encounter. It can shorten delays, limit conflict over analgesia, and create a clearer pathway from arrival to treatment.
Quality improvement strategies likely help through a different mechanism: standardization. In a condition vulnerable to variation in triage, analgesia timing, and follow-up, even modest process improvements may alter whether patients return for care or avoid it after a difficult visit. The review does not claim that these interventions solve the problem, but it does show that structured responses can reduce avoidance where generic systems fail.
The Evidence Base Still Leaves Gaps for Multi-Level Intervention Design
The review maps the literature rather than testing a single intervention, so it does not provide a definitive effect size for any one strategy. What it does provide is a clear hierarchy of problems and possible responses. Barriers span the social environment, relationships with clinicians, affordability, and institutional design. Facilitators cluster around communication, individualized care, and patient engagement. Those findings argue for interventions that work across multiple levels instead of relying on one-off fixes.
Research gaps remain visible in the pattern of the evidence itself. The field needs more rigorous evaluation of interventions that connect outpatient support, emergency care, pain protocols, and trust-building strategies. In sickle cell disease, the goal is not merely more encounters with the healthcare system. The more relevant endpoint is safer, earlier, and less adversarial engagement with care before a crisis escalates into hospitalization.
Health systems and health policy will need to address the same recurrent problem from several directions at once: access, communication, cost, and responsiveness. Without that, the barriers identified in this review will continue to pull patients away from care when they most need it.